Furadantin Related Published Studies
Well-designed clinical trials related to Furadantin (Nitrofurantoin)
One week of nitrofurantoin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. [2011.01]
One-day compared with 7-day nitrofurantoin for asymptomatic bacteriuria in pregnancy: a randomized controlled trial. [2009.02]
Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. [2007.11.12]
A randomized, double-blind, placebo-controlled comparison of the effect of nitrofurantoin monohydrate macrocrystals on the development of urinary tract infections after surgery for pelvic organ prolapse and/or stress urinary incontinence with suprapubic catheterization. [2004.07]
Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women. [2003.06.01]
[Prophylaxis of recurrent urinary tract infections in children. Results of an open, controlled and randomized study about the efficacy and tolerance of cefixime compared to nitrofurantoin] [2002.11]
Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. [2002.09]
Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. [1999.11]
A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. [1999.03]
Effect of norfloxacin, trimethoprim-sulfamethoxazole and nitrofurantoin on fecal flora of women with recurrent urinary tract infections. [1997.06]
[Treatment of urinary tract infections with macro-crystalline nitrofurantoin] [1995.06]
A comparative trial of low dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection. [1995.03]
A short-term study of nitrofurantoin prophylaxis in children managed with clean intermittent catheterization. [1994.05]
Nitrofurantoin modified release versus trimethoprim or co-trimoxazole in the treatment of uncomplicated urinary tract infection in general practice. [1994.05]
Fosfomycin trometamol in a single dose versus seven days nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women. [1993.12.17]
Nitrofurantoin versus trimethoprim for low-dose long-term prophylaxis in patients with recurrent urinary tract infections. A prospective randomized study. [1992]
Cefaclor as a prophylactic agent for recurrent urinary infections: a comparative trial with macrocrystalline nitrofurantoin. [1992]
Comparative trial of norfloxacin and macrocrystalline nitrofurantoin (Macrodantin) in the prophylaxis of recurrent urinary tract infection in women. [1991.10]
Long-term prophylaxis with norfloxacin versus nitrofurantoin in women with recurrent urinary tract infection. [1991.06]
Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children. A randomized, double-blind study. [1990.12]
Single dose fosfomycin trometamol versus multiple dose nitrofurantoin in pregnant women with bacteriuria: preliminary results. [1990]
Pyelonephritis in pregnancy. The role of in-hospital management and nitrofurantoin suppression. [1987.12]
A comparative study of pipemidic acid and nitrofurantoin in the treatment of uncomplicated urinary tract infections. [1987.11.21]
Clinical experience with ofloxacin in upper and lower urinary tract infections. A comparison with co-trimoxazole and nitrofurantoin. [1987]
Well-designed clinical trials possibly related to Furadantin (Nitrofurantoin)
Oral antibiotics to prevent postoperative urinary tract infection: a randomized
controlled trial. [2014]
Can a multifaceted educational intervention targeting both nurses and physicians change the prescribing of antibiotics to nursing home residents? A cluster randomized controlled trial. [2011.11]
Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy. [2010.09.08]
The tools of an evidence-based culture: implementing clinical-practice guidelines in an Israeli HMO. [2009.09]
Women's quality of life is decreased by acute cystitis and antibiotic adverse effects associated with treatment. [2005.07.27]
Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis. [2005.07]
[Antibiotics in transurethral resection of the prostate in patients with low risk of infectious complications: randomized prospective comparative study] [2004.01]
Laboratory aspects of asymptomatic bacteriuria in pregnancy. [2002.09]
[Antibiotic resistance of E coli isolated from healthy persons] [2001.09.03]
Randomized trial of antibiotic prophylaxis for combined urodynamics and cystourethroscopy. [1999.05]
In vitro susceptibility of new generation of antibacterial antibiotics against pathogenic bacteria. [1999.02]
Long-term colonization with single and multiple strains of Helicobacter pylori assessed by DNA fingerprinting. [1995.04]
Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. [1995.01.04]
Antibiotic prophylaxis following lower urinary tract instrumentation. [1992.06]
Antibiotic use after cefuroxime prophylaxis in hip and knee joint replacement. [1991.08]
Bacteriuria in the puerperium. Risk factors, screening procedures, and treatment programs. [1990.03]
Prophylactic chemotherapy with fosfomycin trometamol versus placebo during transurethral prostatic resection. [1990]
Prevention of catheter-associated gram-negative bacilluria with norfloxacin by selective decontamination of the bowel and high urinary concentration. [1989.06]
Treatment of bacterial infections of the female urinary tract by immunization of the patients. [1987]
Other research related to Furadantin (Nitrofurantoin)
Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis. [2011.06]
[Antimicrobial and clinical efficacy of nitrofurantoin in the treatment of acute lower urinary tract infections in adults]. [2010.10]
Integrated approach to study the dehydration kinetics of nitrofurantoin monohydrate. [2010.09]
One Week of Nitrofurantoin Before Percutaneous Nephrolithotomy Significantly Reduces Upper Tract Infection and Urosepsis: A Prospective Controlled Study. [2010.06.08]
Neurogenic bladder: a complication after endoscopic adhesiolysis with return of bladder function while using nitrofurantoin. [2010.05.01]
Nitrofurantoin pulmonary toxicity: neglected threat. [2010.04]
Acute renal failure from nitrofurantoin-induced acute granulomatous interstitial nephritis. [2010.01]
Probable nitrofurantoin-induced bronchiolitis obliterans with organizing pneumonia. [2009.11.01]
Effect of pregnancy on nitrofurantoin disposition in mice. [2009.11]
Nitrofurantoin-induced systemic inflammatory response syndrome. [2009.10]
Nitrofurantoin-induced acute liver damage in pregnancy. [2009.09]
[Rapid resolution of nitrofurantoin-induced interstitial lung disease] [2009.07]
DRESS syndrome caused by nitrofurantoin. [2009.04]
Differential effects of chrysin on nitrofurantoin pharmacokinetics mediated by intestinal breast cancer resistance protein in rats and mice. [2009]
Nitrofurantoin: the return of an old friend in the wake of growing resistance. [2008.12]
N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918) as a chemical ATP-binding cassette transporter family G member 2 (Abcg2) knockout model to study nitrofurantoin transfer into milk. [2008.12]
Nitrofurantoin-associated bronchiolitis obliterans organizing pneumonia: report of a case. [2008.09]
The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects. [2008.08]
Chronic eosinophilic pneumonia secondary to long-term use of nitrofurantoin: high-resolution computed tomography findings. [2008.03]
[Nitrofurantoin-induced lung disease: about two cases] [2008.02]
Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. [2008.01]
Breast cancer resistance protein 1 limits fetal distribution of nitrofurantoin in the pregnant mouse. [2007.12]
Nitrofurantoin neuropathy: a forgotten adverse effect. [2007.08]
Nitrofurantoin-induced lung- and hepatotoxicity. [2007.04]
Severe nitrofurantoin lung disease resolving without the use of steroids. [2007.04]
[Fosfomycin, co-trimoxazole and nitrofurantoin in the treatment of recurrent uncomplicated urinary tract infections in type 2 diabetes mellitus] [2007]
[Efficacy of nitrofurantoin in the treatment of chronic urinary tract infections in patients with type 2 diabetes mellitus] [2006.11]
New uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisited. [2006.11]
[Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?] [2006.10]
Giant cell interstitial pneumonia associated with nitrofurantoin. [2006.05]
Recurrent acute nitrofurantoin-induced pulmonary toxicity. [2006.05]
Chronic nitrofurantoin-induced lung disease. [2005.10]
Comparison of genomic damage caused by 5-nitrofurantoin in young and adult mice using the in vivo micronucleus assay. [2005.07]
Piperitone from Mentha longifolia var. chorodictya Rech F. reduces the nitrofurantoin resistance of strains of enterobacteriaceae. [2004.11]
Increased treatment failure after 3-days' courses of nitrofurantoin and trimethoprim for urinary tract infections in women: a population-based retrospective cohort study using the PHARMO database. [2004.08]
Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children. [2004.08]
Pulmonary and hepatic toxicity due to nitrofurantoin and fluconazole treatment. [2004.04]
[Liver cirrhosis due to chronic use of nitrofurantoin] [2004.01.31]
Nitrofurantoin-induced chronic active hepatitis. [2002.03]
Cytogenetic analysis of peripheral blood lymphocytes of children treated with nitrofurantoin for recurrent urinary tract infection. [2002.01]
Active transport of nitrofurantoin into human milk. [2001.06]
The establishment of conditions to efficiently screen photosynthesis-deficient mutants of Synechocystis sp. PCC 6803 by nitrofurantoin treatment. [2001.04]
Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance. [2001.04]
Nitrofurantoin and congenital abnormalities. [2001.03]
Protection against nitrofurantoin-induced oxidative stress by coelenterazine analogues and their oxidation products in rat hepatocytes. [2001.03]
Active transport of nitrofurantoin into rat milk. [2001]
Ocular myasthenia and nitrofurantoin. [2000.10]
Evaluation of nitrofurantoin combination therapy of metronidazole-sensitive and -resistant Helicobacter pylori infections in mice. [2000.10]
[Hemolytic anemia in a newborn after maternal treatment with nitrofurantoin at the end of pregnancy] [2000.07]
A new in vitro/in vivo kinetic correlation method for nitrofurantoin matrix tablet formulations. [2000.07]
Nitrofurantoin-induced lung disease: two cases demonstrating resolution of apparently irreversible CT abnormalities. [2000.03]
Bronchiolitis obliterans organising pneumonia associated with the use of nitrofurantoin. [2000.03]
[Hepatic toxicity of nitrofurantoin. Cases reported to the Center for Monitoring Adverse Drug Reactions 1968-1998] [1999.11.29]
Transient acute renal failure due to nitrofurantoin poisoning. [1999.11]
Design and biopharmaceutical evaluation of nitrofurantoin-loaded Eudragit RS100 micropellets. [1999.08]
Preparation and biopharmaceutical evaluation of nitrofurantoin loaded Eudragit RS100 and Eudragit RL 100 micropellets. [1999.05]
Nitrofurantoin-induced immune-mediated lung and liver disease. [1999.05]
Nitrofurantoin-associated Sweet's syndrome. [1999.03]
|